InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Holm-Jorgensen Rasmus. Officer active across 1 company, notably Acrivon Therapeutics, Inc.. In total, 8 disclosures have been recorded. Activity tracked since 14 November 2022. The latest transaction was filed on 14 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Holm-Jorgensen Rasmus is a declarant linked to Acrivon Therapeutics, Inc., where he serves as Chief Financial Officer. He has 8 filings in total, and among the sampled recent filings from 2022-11-16 to 2025-02-19, the reported amounts are all tax withholding, with individual amounts including EUR 31504.80785987823, EUR 6977.874865500276, EUR 2844.759461722698, EUR 2758.922404568807, EUR 2345.690896777689, and EUR 2248.473866831481.